Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

takotsubo cardiomyopathy/kalis

Nuoroda įrašoma į mainų sritį
9 rezultatus

Acute transient spinal paralysis and cardiac symptoms following an accidental epidural potassium infusion - a case report.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND To describe a case of an accidental epidural potassium infusion leading to an acute transient spinal paralysis and cardiac symptoms and review the literature on that topic. METHODS We report the case of an accidental infusion of 900 mg potassium chloride 7.45% (KCl) into the epidural

Transient left ventricular apical ballooning syndrome after inadvertent epidural administration of potassium chloride.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
A 32-year-old white female presented for her first Caesarean section. The procedure was performed under epidural anaesthesia. The anaesthetic drug was inadvertently diluted with potassium chloride instead of normal saline. This solution was then injected via an epidural catheter into the epidural

Cardioprotective effects of isoflurane in a rat model of stress-induced cardiomyopathy (takotsubo).

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND Stress-induced cardiomyopathy (SIC) is a common syndrome with substantial morbidity and mortality. SIC is common in intensive care units' patients. No therapeutic intervention for SIC has been evaluated in randomized clinical trial so far. Our aim was to investigate whether isoflurane is

Refractory hypoglycemia and subsequent cardiogenic shock in starvation and refeeding: report of three cases.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE Although starvation is associated with high in-hospital mortality, its related cardiac complications are not sufficiently understood. The aim of this study was to determine the clinical course and pathogenesis of cardiac complications in malnourished patients. METHODS We reviewed three

Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Despite the progress in the management of cerebral arterial aneurysms, subarachnoid hemorrhage (SAH) remains the major cause of neurological disability. While SAH-related deaths usually occur as a result of brain impairment due to hemorrhage, permanent neurological deficits are caused by cerebral

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Levosimendan was first approved for clinic use in 2000, when authorisation was granted by Swedish regulatory authorities for the haemodynamic stabilisation of patients with acutely decompensated chronic heart failure. In the ensuing 20 years, this distinctive inodilator, which enhances cardiac

Acute Systemic Complications of Convulsive Status Epilepticus-A Systematic Review.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Status epilepticus is a neurologic emergency with high morbidity and mortality requiring neurointensive care and treatment of systemic complications. This systematic review compiles the current literature on acute systemic complications of generalized convulsive status epilepticus in adults and

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Levosimendan was first approved for clinical use in 2000, when authorization was granted by Swedish regulatory authorities for the hemodynamic stabilization of patients with acutely decompensated chronic heart failure (HF). In the ensuing 20 years, this distinctive inodilator, which enhances cardiac

Levosimendan: current data, clinical use and future development.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Levosimendan is an inodilator indicated for the short-term treatment of acutely decompensated severe chronic heart failure, and in situations where conventional therapy is not considered adequate. The principal pharmacological effects of levosimendan are (a) increased cardiac contractility by
Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge